For example, naltrexone-bupropion is not suitable for patients with uncontrolled hypertension [62] and phentermine is contraindicated in patients with a history of cardiovascular disease [63]
Mosenzon O, Blicher TM, Rosenlund S, Eriksson JW, Heller S, Hels OH, et al
So as of May 2026, the Bridge is the only confirmed pathway for Medicare to cover GLP-1s for weight loss
The key is working with providers who understand the full picture who can assess your skins current condition, understand the context of any recent body changes, and recommend a treatment plan that is both realistic and aligned with your long-term goals
Monitor TSH levels every 3 months during Retatrutide treatment as thyroid medication needs may change with significant weight loss
Get more from your GLP-1 no matter where you get the Rx GLP-1s help change your weight